Denali Therapeutics Inc.DNLINASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank80
3Y CAGR+42.7%
5Y CAGR+35.9%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+42.7%/yr
vs +9.9%/yr prior
5Y CAGR
+35.9%/yr
Recent acceleration
Acceleration
+32.8pp
Accelerating
Percentile
P80
Within normal range
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $42.90M | -33.6% |
| 2024 | $64.64M | +25.5% |
| 2023 | $51.51M | +248.6% |
| 2022 | $14.77M | +221.5% |
| 2021 | $4.59M | -50.3% |
| 2020 | $9.24M | -39.3% |
| 2019 | $15.22M | +50.2% |
| 2018 | $10.13M | +418.3% |
| 2017 | $1.96M | +150.3% |
| 2016 | $781000.00 | - |